Correction: Elacestrant: First Approval

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Correction: Elacestrant: First Approval ; volume:83 ; number:18 ; day:25 ; month:11 ; year:2023 ; pages:1735 ; date:12.2023
Drugs ; 83, Heft 18 (25.11.2023), 1735, 12.2023

Klassifikation
Recht

Urheber
Hoy, Sheridan M.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s40265-023-01978-2
URN
urn:nbn:de:101:1-2024030321182006676019
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:44 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Hoy, Sheridan M.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Correction: Eplontersen: First Approval

Correction: Eplontersen: First Approval

Correction: Zilucoplan: First Approval

Correction: Zilucoplan: First Approval

Correction: Vorasidenib: First Approval

Correction: Vorasidenib: First Approval

Correction to: Lonafarnib: First Approval

Correction to: Lonafarnib: First Approval

Correction to: Pexidartinib: First Approval

Correction to: Pexidartinib: First Approval

Correction to: Nedosiran: First Approval

Correction to: Nedosiran: First Approval

Correction to: Lenacapavir: First Approval

Correction to: Lenacapavir: First Approval

Correction to: Zavegepant: First Approval

Correction to: Zavegepant: First Approval

Correction to: Spesolimab: First Approval

Correction to: Spesolimab: First Approval

Correction to: Sparsentan: First Approval

Correction to: Sparsentan: First Approval

Correction to: Filgotinib: First Approval

Correction to: Filgotinib: First Approval

Correction to: Ubrogepant: First Approval

Correction to: Ubrogepant: First Approval

Verbundene Objekte